Format

Send to

Choose Destination
J Ginseng Res. 2011 Nov;35(4):457-61. doi: 10.5142/jgr.2011.35.4.457.

Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with korean red ginseng.

Author information

1
Department of Neurology, Seoul Medical Center, Seoul 131-130, Korea.

Abstract

A 24-week randomized open-label study with Korean red ginseng (KRG) showed cognitive benefits in patients with Alzheimer's disease. To further determine long-term effect of KRG, the subjects were recruited to be followed up to 2 yr. Cognitive function was evaluated every 12 wk using the Alzheimer's Disease Assessment Scale (ADAS) and the Korean version of the Mini Mental Status Examination (K-MMSE) with the maintaining dose of 4.5 g or 9.0 g KRG per d. At 24 wk, there had been a significant improvement in KRG-treated groups. In the long-term evaluation of the efficacy of KRG after 24 wk, the improved MMSE score remained without significant decline at the 48th and 96th wk. ADAS-cog showed similar findings. Maximum improvement was found around week 24. In conclusion, the effect of KRG on cognitive functions was sustained for 2 yr follow-up, indicating feasible efficacies of long-term follow-up for Alzheimer's disease.

KEYWORDS:

Alzheimer disease; Korean red ginseng; Long term effect; Panax ginseng

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center